Biodistribution of 89Zirconium-labelled GSK2398852 Using PET Imaging
Clinical trial NCT03417830 · TERMINATED
Trial details
- NCT number
- NCT03417830
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-06
- Primary completion
- 2018-07-20
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.